Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Addiction Biology
|
April 22, 2008
The endocannabinoid system: emotion, learning and addiction
Fabrício A Moreira, Beat Lutz
Current Topics in Behavioral Neurosciences
|
February 11, 2011
Cannabinoids and anxiety
Fabrício A Moreira, Carsten T Wotjak
Physiology & Behavior
|
March 7, 2008
Lack of effects of clomipramine on Fos and NADPH-diaphorase double-staining in the periaqueductal gray after exposure to an innate fear stimulus
Fabrício A Moreira, Francisco S Guimarães
European Journal of Pharmacology
|
April 21, 2005
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
Fabrício A Moreira, Francisco S Guimarães
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
July 7, 2009
The psychiatric side-effects of rimonabant
Fabrício A Moreira, José Alexandre S Crippa
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 17, 2009
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabrício A Moreira, Maximilian Grieb, Beat Lutz
Behavioural Pharmacology
|
January 25, 2021
The endocannabinoid system and drug-associated contextual memories
Laila Asth, Aline C Santos, Fabrício A Moreira
Pharmacology, Biochemistry, and Behavior
|
May 29, 2013
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze
Pedro H Gobira, Daniele C Aguiar, Fabrício A Moreira
International Review of Neurobiology
|
July 19, 2024
Cannabidiol and addiction
Rayssa C Briânis, Fabrício A Moreira, Lia P Iglesias
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 1, 2006
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabrício A Moreira, Daniele C Aguiar, Francisco S Guimarães
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Addiction Biology
|
April 22, 2008
The endocannabinoid system: emotion, learning and addiction
Fabrício A Moreira, Beat Lutz
Current Topics in Behavioral Neurosciences
|
February 11, 2011
Cannabinoids and anxiety
Fabrício A Moreira, Carsten T Wotjak
Physiology & Behavior
|
March 7, 2008
Lack of effects of clomipramine on Fos and NADPH-diaphorase double-staining in the periaqueductal gray after exposure to an innate fear stimulus
Fabrício A Moreira, Francisco S Guimarães
European Journal of Pharmacology
|
April 21, 2005
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
Fabrício A Moreira, Francisco S Guimarães
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
July 7, 2009
The psychiatric side-effects of rimonabant
Fabrício A Moreira, José Alexandre S Crippa
Best Practice & Research. Clinical Endocrinology & Metabolism
|
March 17, 2009
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabrício A Moreira, Maximilian Grieb, Beat Lutz
Behavioural Pharmacology
|
January 25, 2021
The endocannabinoid system and drug-associated contextual memories
Laila Asth, Aline C Santos, Fabrício A Moreira
Pharmacology, Biochemistry, and Behavior
|
May 29, 2013
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze
Pedro H Gobira, Daniele C Aguiar, Fabrício A Moreira
International Review of Neurobiology
|
July 19, 2024
Cannabidiol and addiction
Rayssa C Briânis, Fabrício A Moreira, Lia P Iglesias
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 1, 2006
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabrício A Moreira, Daniele C Aguiar, Francisco S Guimarães
Page
of 7